GLP-1 Vs. SGLT-2 In Geriatric Patients: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

13 August 2026

  • curprev 11:1811:18, 13 August 2026‎ Grazyna48P talk contribs‎ 6,497 bytes +6,497‎ Created page with "<br>Researchers compare the cardiovascular effectiveness and safety of GLP-1 agonists and SGLT-2 inhibitors in older adults with diabetes. Both sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP1RA) have been shown to have cardiovascular benefits in patients less than 65 years old. Current guidelines recommend initiating a GLP1RA or SGLT2i in patients with a high risk for cardiovascular disease, established ASCVD, chroni..."
Retrieved from "https://ewueduwiki.club:443/index.php?title=GLP-1_Vs._SGLT-2_In_Geriatric_Patients"